7.065

2.15% -0.155

Journey Medical Corp (DERM)

Overview News Price History Financials Discussions Forecast

Journey Medical Corp stock is traded at $7.065, with a volume of 55,274. It is down -2.15% in the last 24 hours and up +18.34% over the past month. Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

Previous Close:

$7.22

Open:

$7.29

24h Volume:

55,274

Relative Volume:

0.21

Market Cap:

$194.67M

Revenue:

$61.86M

Net Income/Loss:

$-11.43M

P/E Ratio:

-14.66

EPS:

-0.4818

Net Cash Flow:

$-12.52M

1W Performance:

-0.21%

1M Performance:

+18.34%

6M Performance:

-5.80%

1Y Performance:

-0.63%

1-Day Range:

$7.00

$7.33

1-Week Range:

$6.89

$7.33

52-Week Range:

$4.31

$9.555

Journey Medical Corp Stock (DERM) Company Profile

Name

Journey Medical Corp

Sector

Healthcare (1100)

Industry

Drug Manufacturers - Specialty & Generic (86)

Phone

480-434-6670

Address

9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE

Employee

Twitter

Next Earnings Date

2026-08-11

Latest SEC Filings

DERM's Discussions on Twitter

Compare DERM vs TAK, HLN, TEVA, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DERM Journey Medical Corp	7.07	195.22M	61.86M	-11.43M	-12.52M	-0.4818
TAK Takeda Pharmaceutical Co Adr	16.96	52.99B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.835	43.25B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	34.67	40.34B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	76.45	31.36B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	559.27	23.60B	3.17B	1.29B	1.01B	27.09

Journey Medical Corp Stock (DERM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-25-25	Initiated	H.C. Wainwright	Buy
Jul-30-25	Resumed	B. Riley Securities	Buy
Aug-22-24	Initiated	Rodman & Renshaw	Buy
Jun-28-24	Resumed	ROTH MKM	Buy
Dec-07-21	Initiated	B. Riley Securities	Buy

Journey Medical Corp Stock (DERM) Latest News

Jul 02, 2026

Form 4 Journey Medical Corp For: 2 July By Investing.com - Investing.com Canada

Jul 02, 2026

Jul 01, 2026

DERM Stock Price, Quote & Chart - ChartMill

Jul 01, 2026

Jun 26, 2026

Form 4 Journey Medical Corp For: 26 June By Investing.com - Investing.com Nigeria

Jun 26, 2026

Director at Journey Medical (DERM) receives 10,000 restricted stock units - Stock Titan

Jun 26, 2026

Journey Medical (DERM) director awarded 10,000 restricted stock units in equity grant - Stock Titan

Jun 26, 2026

Journey Medical (DERM) director receives 10,000 RSUs vesting in 2027 - Stock Titan

Jun 26, 2026

Journey Medical (DERM) director granted 10,000 RSUs, holds over 397K shares - Stock Titan

Jun 26, 2026

Merck KGaA (MKKGY) Soars 5.3%: Is Further Upside Left in the Stock? - Yahoo! Finance Canada

Jun 26, 2026

Journey Medical Corporation (DERM) Files Form 8-K with SEC – Key Company Details and Filing Information (June 24, 2026) – Minichart - Minichart

Jun 26, 2026

Journey Medical Shareholders Back Board and Auditor Slate - TipRanks

Jun 26, 2026

Journey Medical (DERM) 2026 meeting backs all directors and re-approves KPMG - Stock Titan

Jun 26, 2026

Journey Medical Corp. Actuals & Estimates (NASDAQ:DERM) - TradingView

Jun 26, 2026

Jun 25, 2026

Journey Medical (DERM) Stock Draws Fresh Price Target Split After Fortress Valuation Changes - Yahoo Finance

Jun 25, 2026

Jun 24, 2026